Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Koschel, C. Cardoso, B. Wiedemann, G. Höffken, M. Halank (Coswig, Dresden, Germany). Prevalance and outcomes of pulmonary hypertension in chronic hypersensitivity pneumonitis. Eur Respir J 2011; 38: Suppl. 55, 3739

Member's Comments

No comment yet.

Related content which might interest you: A haemodynamic study of pulmonary hypertension in chronic hypersensitivity pneumonitis Source: Eur Respir J 2014; 44: 415-424 Year: 2014 Pulmonary hemodynamics and mortality in chronic hypersensitivity pneumonitis Source: International Congress 2017 – Rare diseases Year: 2017 Pulmonary haemodynamics and mortality in chronic hypersensitivity pneumonitis Source: Eur Respir J, 51 (6) 1800430; 10.1183/13993003.00430-2018 Year: 2018 Pulmonary hypertension in hypersensitivity pneumonitis. Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 Pulmonary hypertension in hypersensitivity pneumonitis Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Secondary pulmonary hypertension in chronic obstructive pulmonary disease and systemic lupus erythematosus- pathophysiology and treatment Source: Eur Respir J 2004; 24: Suppl. 48, 59s Year: 2004 Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 40: 93-100 Year: 2012 Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis Source: Eur Respir J, 58 (2) 2003345; 10.1183/13993003.03345-2020 Year: 2021 Prevalence and clinical characteristics of blood eosinophilia in patients with acute exacerbation of chronic obstructive pulmonary disease in China Source: International Congress 2017 – COPD biomarkers Year: 2017 Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis Source: Virtual Congress 2020 – Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis Year: 2020 Prevalence and impact of WHO group 3 pulmonary hypertension in advanced idiopathic nonspecific interstitial pneumonia Source: Eur Respir J, 52 (1) 1800545; 10.1183/13993003.00545-2018 Year: 2018 Chronic thromboembolic pulmonary hypertension as a cause of dyspnoea in an older patient with a complex history Source: Eur Respir Rev 2009; 18: 170-173 Year: 2009 Chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension are the conditions predisposing to non-tuberculous mycobacterial lung disease (NTMLD) Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Incidence of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 Diagnosis of chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2017; 26: 160108 Year: 2017 Chronic hypersensitivity pneumonitis with familial history of interstitial lung disease Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Blood eosinophilia in chronic obstructive pulmonary disease: impact on exacerbations risk and severity Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Systemic inflammation and pulmonary hypertension in patients with bronchial asthma Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008